ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

ACR Convergence 2024

November 14-19, 2024. Washington, DC.

View by Number View by Title View Sessions

Sunday, November 17, 2024

10:30AM-12:30PM
Abstract Number: 1237
The Art of Choosing Together: Unveiling the Patient’s Perspective in Rheumatology
Patient Outcomes, Preferences, & Attitudes Poster II
10:30AM-12:30PM
Abstract Number: 0913
The Association Between PTPN2 and Leukopenia in New Users of Azathioprine
Genetics, Genomics & Proteomics Poster
10:30AM-12:30PM
Abstract Number: 1325
The Association Between the Number of Teeth and All-Cause as Well as Cardiovascular Mortality Among Patients with RA: NHANES from 1999 to 2004
RA – Diagnosis, Manifestations, & Outcomes Poster II
10:30AM-12:30PM
Abstract Number: 1436
The Association of Cigarette Smoking with Radiographic Progression in Psoriatic Arthritis
SpA Including PsA – Diagnosis, Manifestations, & Outcomes Poster II
10:30AM-12:30PM
Abstract Number: 1354
The Association of Genetic Variation in PTPN22 and Rheumatoid Arthritis Disease Activity
RA – Diagnosis, Manifestations, & Outcomes Poster II
10:30AM-12:30PM
Abstract Number: 1335
The Association of Patient-Reported Non-Articular Pain with Musculoskeletal Pain Diagnoses and RA Disease Activity in a Prospective Real-World Cohort of Patients with Early RA
RA – Diagnosis, Manifestations, & Outcomes Poster II
10:30AM-12:30PM
Abstract Number: 1583
The Association of Weakpositive Anti-RNA Polymerase III Antibodies with the Diagnosis and Complications of Systemic Sclerosis and Other Systemic Autoimmune Diseases
Systemic Sclerosis & Related Disorders – Clinical Poster II
10:30AM-12:30PM
Abstract Number: 1352
The Associations Between Genetic Factors and Rheumatoid Arthritis Treatment Patterns: Data from Two Large Healthcare Systems
RA – Diagnosis, Manifestations, & Outcomes Poster II
10:30AM-12:30PM
Abstract Number: 1281
The Brazilian Registry of Juvenile Dermatomyositis: Relationship Between Ultraviolet Radiation and Laboratory Markers of Juvenile Dermatomyositis in a Tropical Country
Pediatric Rheumatology – Clinical Poster II
10:30AM-12:30PM
Abstract Number: 0981
The Causal Effect of Sex Hormone-related Drugs on the Risk of Osteoarthritis – A Mendelian Randomization Study
Epidemiology & Public Health Poster II
10:30AM-12:30PM
Abstract Number: 0930
The Common Form of the Inflammatory Skin Disease Hidradenitis Suppurativa Is Associated with Low Nicastrin Expression in Dermal Fibroblasts
Innate Immunity Poster
10:30AM-12:30PM
Abstract Number: 1101
The Contemporary Prevalence of Comorbid Gout and Chronic Kidney Disease, Two Common Conditions with High Morbidity, in the US General Population
Metabolic & Crystal Arthropathies – Basic & Clinical Science Poster II
10:30AM-12:30PM
Abstract Number: 1050
The Cost-effectiveness of Glucagon-Like Peptide-1 Receptor Agonists (GLP1RAs) for Patients with Knee Osteoarthritis and Obesity
Health Services Research – ACR/ARP Poster II
10:30AM-12:30PM
Abstract Number: 0924
The Cytosolic DNA Sensor AIM2 Regulates Bone Homeostasis Through Bone Progenitor Cell Differentiation
Innate Immunity Poster
10:30AM-12:30PM
Abstract Number: 1361
The Effect of Disease Activity on Cardiovascular Risk Varies According to Rheumatoid Factor and Anticitrullinated Protein Antibody Status in Patients with Rheumatoid Arthritis
RA – Diagnosis, Manifestations, & Outcomes Poster II
  • «Previous Page
  • 1
  • …
  • 43
  • 44
  • 45
  • 46
  • 47
  • …
  • 59
  • Next Page»
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology